Melanoma
News
Few new cancer drugs replace current standards of care
Newer drugs could benefit patients but could increase the cost of care.
News
FDA approves new immunotherapy combo for metastatic melanoma
Approval is based on findings that show median progression-free survival of 10.1 months.
News
Adverse skin effects of cancer immunotherapy reviewed
“The desirable, immune-mediated oncologic response is often achieved at the cost of immune-related adverse events (irAEs) that may potentially...
Opinion
Ways to lessen toxic effects of chemo in older adults
Three recent high-quality randomized trials evaluated the use of geriatric assessment in older adults with cancer.
News
Complex link between gut microbiome and immunotherapy response in advanced melanoma
Previous studies have identified the gut microbiome as “a potential biomarker of response as well as a therapeutic target” in melanoma and other...
News
High early recurrence rates with Merkel cell carcinoma
Approximately 95% of all recurrences happened within 3 years of the initial diagnosis in the prospective cohort study.
Opinion
“I didn’t want to meet you.” Dispelling myths about palliative care
This is the first installment of “Diminutio,” a column by Sarah D’Ambruoso, NP, a palliative care nurse in oncology. Today, she shares stories...
News
Pioneering test predicts return of malignant melanoma
The test will aid clinicians to identify genuinely low-risk patients diagnosed with an early-stage melanoma, the study’s senior author said.
News
U.S. cancer deaths continue to fall, especially lung cancer
There has been an overall decline of 32% in cancer deaths as of 2019.
News
Soon-to-be medical student awarded $10K after spotting melanoma
“The mole on the back of your neck is possibly cancerous. Please go see a doctor!”
